Sex Differences in Non-Acute Myocardial Infarction Cardiogenic Shock: Insights from the Northwell-Shock Registry

Abstract

Background: Previous studies had explored the role of patients? sex in defining clinical presentation, management, and outcomes among patients with acute myocardial infarction (AMI) related cardiogenic shock (CS). However, the effect of sex among patients with non-acute myocardial infarction related CS (nonAMI-CS) is less well defined. Method: Adult patients treated for CS (International Classification of Diseases, Tenth Revision, [ICD-10] code R57.0) between 2016 and 2022 across eleven hospitals within our health system, all utilizing a shared electronic medical record, were included. CS etiologies were defined as AMI, nonAMI and others. For nonAMI-CS patients, stratification by sex was performed to compare the incidence of specific etiologies, baseline characteristics, management and outcomes between men and women. Comparisons were conducted using t-tests, Wilcoxon rank-sum tests or chi-square tests. Logistic regression models were developed to examine the effect of sex on in-hospital mortality, management strategies, and mortality predictors. Result: 2,256 patients admitted for nonAMI-CS were identified. Women comprised 36% of the study cohort and were older and had more medical comorbidities. There was no significant difference in presenting CS severity as measured by Society for Cardiovascular Angiography and Interventions (SCAI) stages, APACHE scores or in-hospital mortality. There were significant differences in the specific etiologies of nonAMI-CS, where women had more valvular cardiogenic shock. Women received fewer invasive interventions including pulmonary artery catheter (PAC) and intra-aortic balloon pump (IABP) when compared to men but similar rates of Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO). Lastly, women were more likely to be discharged to skilled nursing facilities while men more likely to home. Conclusion: Significant sex-specific differences exist in nonAMI-CS including specific etiologies, management strategies, and factors associated with mortality. Despite older age, more comorbidities and lower rates of invasive management procedures, women had similar survival to men but higher need for skilled facilities upon discharge.

Competing Interest Statement

Jaime Hernandez-Montfort serves as a consultant for Abbott, Abiomed, and Boston Scientific. Gerin R. Stevens serves as a consultant for Ancora Heart and Vectorious Medical.

Funding Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Northwell-Shock Registry is a multi-center retrospective observational study of patients with CS. It was approved by the Northwell Health Institutional Review Board. This registry was deemed to pose minimal risk to the study subjects and a waiver of informed consent was obtained. Patient data are de-identified and stored in a secure password-protected database.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The raw data supporting the conclusions of this article will be made available by the authors upon request, without reservation.

留言 (0)

沒有登入
gif